| Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference AS Levey, KU Eckardt, NM Dorman, SL Christiansen, EJ Hoorn, ... Kidney international 97 (6), 1117-1129, 2020 | 621 | 2020 |
| Interleukin-6 signaling drives fibrosis in unresolved inflammation CA Fielding, GW Jones, RM McLoughlin, L McLeod, VJ Hammond, ... Immunity 40 (1), 40-50, 2014 | 379 | 2014 |
| Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival M Lambie, J Chess, KL Donovan, YL Kim, JY Do, HB Lee, H Noh, ... Journal of the American Society of Nephrology 24 (12), 2071-2080, 2013 | 201 | 2013 |
| Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis—position paper for ISPD: 2017 update EA Brown, J Bargman, W Van Biesen, MY Chang, FO Finkelstein, H Hurst, ... Peritoneal Dialysis International 37 (4), 362-374, 2017 | 179 | 2017 |
| ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I–assessment and management of various cardiovascular risk factors AYM Wang, KS Brimble, G Brunier, SG Holt, V Jha, DW Johnson, ... Peritoneal Dialysis International 35 (4), 379-387, 2015 | 170 | 2015 |
| Establishing a core outcome set for peritoneal dialysis: report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) consensus workshop KE Manera, DW Johnson, JC Craig, JI Shen, T Gutman, Y Cho, ... American Journal of Kidney Diseases 75 (3), 404-412, 2020 | 136 | 2020 |
| The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis J Perl, SJ Davies, M Lambie, RL Pisoni, K McCullough, DW Johnson, ... Peritoneal Dialysis International 36 (3), 297-307, 2016 | 135 | 2016 |
| The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made ML Lambie, B John, L Mushahar, C Huckvale, SJ Davies Kidney international 78 (6), 611-618, 2010 | 120 | 2010 |
| Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis M Tabinor, E Elphick, M Dudson, CS Kwok, M Lambie, SJ Davies Scientific reports 8 (1), 4441, 2018 | 119 | 2018 |
| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 99 | 2023 |
| Determinants of peritoneal membrane function over time SJ Davies, L Mushahar, Z Yu, M Lambie Seminars in nephrology 31 (2), 172-182, 2011 | 99 | 2011 |
| ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention J Morelle, J Stachowska-Pietka, C Öberg, L Gadola, V La Milia, Z Yu, ... Peritoneal Dialysis International 41 (4), 352-372, 2021 | 84 | 2021 |
| ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients Part II–management of various cardiovascular complications AYM Wang, KS Brimble, G Brunier, SG Holt, V Jha, DW Johnson, ... Peritoneal Dialysis International 35 (4), 388-396, 2015 | 77 | 2015 |
| Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study MR Lambie, J Chess, AM Summers, PF Williams, N Topley, SJ Davies, ... Nephrology Dialysis Transplantation 31 (3), 480-486, 2016 | 64 | 2016 |
| UK Renal Registry C Byrne, F Caskey, C Castledine, A Dawnay, D Ford, S Fraser, ... Nephron 139 (1), 1-12, 2018 | 58 | 2018 |
| Starting and withdrawing haemodialysis—associations between nephrologists' opinions, patient characteristics and practice patterns (data from the Dialysis Outcomes and … M Lambie, HC Rayner, JL Bragg-Gresham, RL Pisoni, VE Andreucci, ... Nephrology Dialysis Transplantation 21 (10), 2814-2820, 2006 | 58 | 2006 |
| AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis J Morelle, C Marechal, Z Yu, H Debaix, T Corre, M Lambie, M Verduijn, ... New England Journal of Medicine 385 (17), 1570-1580, 2021 | 53 | 2021 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 50 | 2023 |
| Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference J Perl, EA Brown, CT Chan, C Couchoud, SJ Davies, R Kazancioğlu, ... Kidney international 103 (5), 842-858, 2023 | 46 | 2023 |
| Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis M Lambie, M Bonomini, SJ Davies, D Accili, A Arduini, V Zammit Trends in Endocrinology & Metabolism 32 (9), 721-730, 2021 | 44 | 2021 |
Simon J DaviesProfessor of Nephrology and Dialysis Medicine, Keele University在 keele.ac.uk 的电子邮件经过验证
Simon J DaviesProfessor of Nephrology and Dialysis Medicine, Keele University在 keele.ac.uk 的电子邮件经过验证
Nicholas TopleyCardiff University School of Medicine在 cf.ac.uk 的电子邮件经过验证